National Health Scan Stock Performance
| GEGR Stock | USD 0.0007 0.00 0.00% |
The company secures a Beta (Market Risk) of 0.7, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, National Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding National Health is expected to be smaller as well. At this point, National Health Scan has a negative expected return of -1.24%. Please make sure to verify National Health's jensen alpha and kurtosis , to decide if National Health Scan performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days National Health Scan has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unsteady performance in the last few months, the Stock's technical and fundamental indicators remain relatively invariable which may send shares a bit higher in August 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
National |
National Health Relative Risk vs. Return Landscape
If you would invest 0.22 in National Health Scan on April 25, 2025 and sell it today you would lose (0.15) from holding National Health Scan or give up 68.18% of portfolio value over 90 days. National Health Scan is currently does not generate positive expected returns and assumes 9.8494% risk (volatility on return distribution) over the 90 days horizon. In different words, 88% of pink sheets are less volatile than National, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
National Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for National Health's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as National Health Scan, and traders can use it to determine the average amount a National Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1261
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GEGR |
Estimated Market Risk
| 9.85 actual daily | 88 88% of assets are less volatile |
Expected Return
| -1.24 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average National Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of National Health by adding National Health to a well-diversified portfolio.
National Health Fundamentals Growth
National Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of National Health, and National Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on National Pink Sheet performance.
| Cash Flow From Operations | (19.16 K) | |||
| Total Asset | 455 | |||
| Retained Earnings | (8.35 M) | |||
| Current Liabilities | 36 K | |||
About National Health Performance
Assessing National Health's fundamental ratios provides investors with valuable insights into National Health's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the National Health is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
iWeb Corporation operates as a medical or healthcare industry business incubator. Among the businesses it has nurtured are Radiology.com, an Internet-based radiology services and systems company, and WebMRI.com, an MRI systems design and OEM company. iWeb Corporation was founded in 1995 and is based in Los Angeles, California. GAENSEL ENERGY operates under Conglomerates classification in the United States and is traded on OTC Exchange.Things to note about National Health Scan performance evaluation
Checking the ongoing alerts about National Health for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for National Health Scan help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| National Health Scan generated a negative expected return over the last 90 days | |
| National Health Scan has high historical volatility and very poor performance | |
| National Health Scan has some characteristics of a very speculative penny stock | |
| National Health Scan has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (661.31 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| National Health generates negative cash flow from operations |
- Analyzing National Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether National Health's stock is overvalued or undervalued compared to its peers.
- Examining National Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating National Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of National Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of National Health's pink sheet. These opinions can provide insight into National Health's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for National Pink Sheet Analysis
When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.